Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2011 1
2012 3
2014 1
2017 1
2018 3
2020 2
2021 6
2022 8
2024 3
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
Kefir: a powerful probiotics with anticancer properties.
Sharifi M, Moridnia A, Mortazavi D, Salehi M, Bagheri M, Sheikhi A. Sharifi M, et al. Among authors: mortazavi d. Med Oncol. 2017 Sep 27;34(11):183. doi: 10.1007/s12032-017-1044-9. Med Oncol. 2017. PMID: 28956261 Review.
KRAS signaling in malignant pleural mesothelioma.
Marazioti A, Krontira AC, Behrend SJ, Giotopoulou GA, Ntaliarda G, Blanquart C, Bayram H, Iliopoulou M, Vreka M, Trassl L, Pepe MAA, Hackl CM, Klotz LV, Weiss SAI, Koch I, Lindner M, Hatz RA, Behr J, Wagner DE, Papadaki H, Antimisiaris SG, Jean D, Deshayes S, Grégoire M, Kayalar Ö, Mortazavi D, Dilege Ş, Tanju S, Erus S, Yavuz Ö, Bulutay P, Fırat P, Psallidas I, Spella M, Giopanou I, Lilis I, Lamort AS, Stathopoulos GT. Marazioti A, et al. Among authors: mortazavi d. EMBO Mol Med. 2022 Feb 7;14(2):e13631. doi: 10.15252/emmm.202013631. Epub 2021 Dec 13. EMBO Mol Med. 2022. PMID: 34898002 Free PMC article.
Epi-miRNAs: Regulators of the Histone Modification Machinery in Human Cancer.
Mortazavi D, Sohrabi B, Mosallaei M, Nariman-Saleh-Fam Z, Bastami M, Mansoori Y, Daraei A, Zununi Vahed S, Navid S, Saadatian Z, Jamialahmadi T, Teng Y, Sahebkar A. Mortazavi D, et al. J Oncol. 2022 Jan 11;2022:4889807. doi: 10.1155/2022/4889807. eCollection 2022. J Oncol. 2022. PMID: 35087589 Free PMC article. Review.
Preventing asthma in high risk kids (PARK) with omalizumab: Design, rationale, methods, lessons learned and adaptation.
Phipatanakul W, Mauger DT, Guilbert TW, Bacharier LB, Durrani S, Jackson DJ, Martinez FD, Fitzpatrick AM, Cunningham A, Kunselman S, Wheatley LM, Bauer C, Davis CM, Geng B, Kloepfer KM, Lapin C, Liu AH, Pongracic JA, Teach SJ, Chmiel J, Gaffin JM, Greenhawt M, Gupta MR, Lai PS, Lemanske RF, Morgan WJ, Sheehan WJ, Stokes J, Thorne PS, Oettgen HC, Israel E; PARK Study Team. Phipatanakul W, et al. Contemp Clin Trials. 2021 Jan;100:106228. doi: 10.1016/j.cct.2020.106228. Epub 2020 Nov 24. Contemp Clin Trials. 2021. PMID: 33242697 Free PMC article. Clinical Trial.
25 results